Kavita V Dharmarajan, MD

Kavita Dharmarajan, MD, MSc, is a board-certified radiation oncologist and Professor of Radiation Oncology, Geriatrics, and Palliative Medicine at the Icahn School of Medicine at Mount Sinai. She also serves as the System Quality Director of Radiation Oncology for the Mount Sinai Health System. Dr. Dharmarajan’s clinical work is focused on providing radiation treatment for metastatic cancers and multiple myeloma using a multidisciplinary, patient-centered approach. She has specialized expertise in advanced radiation techniques including stereotactic radiotherapy and hypofractionation, and she has worked extensively with vulnerable patient populations including those with multiply relapsed/refractory multiple myeloma, oligometastatic disease, and older adults. At Mount Sinai, she developed one of the first care delivery models in the nation to provide specialized multidisciplinary care for persons diagnosed with advanced or incurable cancers.

In addition to her clinical practice, Dr. Dharmarajan is an NIH-funded clinician-investigator and principal investigator on a clinical study being conducted at Mount Sinai evaluating the trajectories of functional status over time among older adults who undergo radiation therapy as part of their cancer treatment. She has been a co-investigator on numerous clinical studies combining radiation therapy and phase I-II anti-cancer agents including those that include the use of immunomodulatory drugs and biospecific agents in multiple myeloma and other cancers. Her work has been supported by the National Institute on Aging, the National Palliative Care Research Center, and the American Medical Association Foundation. She currently serves as the national chairperson of health disparities for a cooperative group study investigating the utility of radiation treatment for asymptomatic bone mets to reduce skeletal-related adverse events (e.g. fractures).

Dr. Dharmarajan has published over 60 original research articles, textbook chapters, and invited papers, and she has served on several national and international committees to promote the education and uptake of radiation therapy for treatment of metastatic disease and multiple myeloma. Her textbook, Palliative Radiation Oncology, was published in 2023. In recognition of her clinical excellence and innovation in research, she has been the recipient of the Association of Community Cancer Center’s Innovator Award and the American Geriatrics Society’s Silverstein Memorial Award.